Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Aug;85(3):383–392. doi: 10.1054/bjoc.2001.1929

Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma

M T Salmela 1, M-L Karjalainen-Lindsberg 2, P Puolakkainen 3,4, U Saarialho-Kere 1
PMCID: PMC2364078  PMID: 11487270

Abstract

Oesophageal adenocarcinoma is believed to arise from metaplastic mucosa in the distal oesophagus, a condition also known as Barrett's oesophagus (BE). BE develops as a result of injury caused by refluxing gastric and duodenal contents and is associated with increased risk of malignant transformation. Matrix metalloproteinases (MMPs) have been implicated in all aspects of tumour progression; tumour growth, basement membrane degradation, invasion and metastatic spread. Using in situ hybridization, we investigated the expression patterns of collagenases-1 and -3, stromelysin-2, matrilysin, metalloelastase and TIMPs-1 and -3 in BE, adenocarcinoma and lymph-node metastases. Matrilysin was expressed abundantly in 12/15 tumours and in 4/6 lymph-node metastases and its expression correlated with the histological aggressiveness of tumour. Matrilysin and metalloelastase were upregulated already in BE. Stromelysin-2 and collagenase-3 expression was detected only in a few tumours. Collagenase-1 was expressed by cancer and stromal cells in 9/15 tumours. Tumour-infiltrating macrophages expressed metalloelastase in 13/15 cancers. TIMPs-1 and -3 were expressed in 12/15 and 11/15 tumours, respectively. Laminin-5 and tenascin were abundantly expressed at the invasive front of poorly differentiated tumours, but not in BE. Our results indicate that matrilysin is the principal MMP expressed by tumour cells in oesophageal adenocarcinoma, and further studies are needed to investigate whether matrilysin or tenascin-C could be used as a predictive marker for progression of BE to cancer. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: collagenase, in situ hybridization, laminin-5, tenascin-C

Full Text

The Full Text of this article is available as a PDF (1.3 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi Y., Yamamoto H., Itoh F., Hinoda Y., Okada Y., Imai K. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers. Gut. 1999 Aug;45(2):252–258. doi: 10.1136/gut.45.2.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahonen M., Baker A. H., Kähäri V. M. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res. 1998 Jun 1;58(11):2310–2315. [PubMed] [Google Scholar]
  3. Airola K., Ahonen M., Johansson N., Heikkilä P., Kere J., Kähäri V. M., Saarialho-Kere U. K. Human TIMP-3 is expressed during fetal development, hair growth cycle, and cancer progression. J Histochem Cytochem. 1998 Apr;46(4):437–447. doi: 10.1177/002215549804600403. [DOI] [PubMed] [Google Scholar]
  4. Airola K., Karonen T., Vaalamo M., Lehti K., Lohi J., Kariniemi A. L., Keski-Oja J., Saarialho-Kere U. K. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer. 1999 May;80(5-6):733–743. doi: 10.1038/sj.bjc.6690417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Anand-Apte B., Pepper M. S., Voest E., Montesano R., Olsen B., Murphy G., Apte S. S., Zetter B. Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci. 1997 Apr;38(5):817–823. [PubMed] [Google Scholar]
  6. Antonioli D. A., Wang H. H. Morphology of Barrett's esophagus and Barrett's-associated dysplasia and adenocarcinoma. Gastroenterol Clin North Am. 1997 Sep;26(3):495–506. doi: 10.1016/s0889-8553(05)70309-5. [DOI] [PubMed] [Google Scholar]
  7. Apte S. S., Olsen B. R., Murphy G. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem. 1995 Jun 16;270(24):14313–14318. doi: 10.1074/jbc.270.24.14313. [DOI] [PubMed] [Google Scholar]
  8. Bonelli L. Barrett's esophagus: results of a multicentric survey. G.O.S.P.E. (Gruppo Operativo per lo Studio delle Precancerosi Esofagee. Endoscopy. 1993 Nov;25(9):652–654. doi: 10.1055/s-2007-1010425. [DOI] [PubMed] [Google Scholar]
  9. Brabletz T., Jung A., Dag S., Hlubek F., Kirchner T. beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am J Pathol. 1999 Oct;155(4):1033–1038. doi: 10.1016/s0002-9440(10)65204-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cazorla M., Hernández L., Nadal A., Balbín M., López J. M., Vizoso F., Fernández P. L., Iwata K., Cardesa A., López-Otín C. Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol. 1998 Oct;186(2):144–150. doi: 10.1002/(SICI)1096-9896(1998100)186:2<144::AID-PATH147>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
  11. Chambers A. F., Matrisian L. M. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997 Sep 3;89(17):1260–1270. doi: 10.1093/jnci/89.17.1260. [DOI] [PubMed] [Google Scholar]
  12. Chandler S., Cossins J., Lury J., Wells G. Macrophage metalloelastase degrades matrix and myelin proteins and processes a tumour necrosis factor-alpha fusion protein. Biochem Biophys Res Commun. 1996 Nov 12;228(2):421–429. doi: 10.1006/bbrc.1996.1677. [DOI] [PubMed] [Google Scholar]
  13. Etoh T., Inoue H., Yoshikawa Y., Barnard G. F., Kitano S., Mori M. Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. Gut. 2000 Jul;47(1):50–56. doi: 10.1136/gut.47.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Feinberg M. W., Jain M. K., Werner F., Sibinga N. E., Wiesel P., Wang H., Topper J. N., Perrella M. A., Lee M. E. Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. J Biol Chem. 2000 Aug 18;275(33):25766–25773. doi: 10.1074/jbc.M002664200. [DOI] [PubMed] [Google Scholar]
  15. Fingleton B. M., Heppner Goss K. J., Crawford H. C., Matrisian L. M. Matrilysin in early stage intestinal tumorigenesis. APMIS. 1999 Jan;107(1):102–110. doi: 10.1111/j.1699-0463.1999.tb01532.x. [DOI] [PubMed] [Google Scholar]
  16. Gronski T. J., Jr, Martin R. L., Kobayashi D. K., Walsh B. C., Holman M. C., Huber M., Van Wart H. E., Shapiro S. D. Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. J Biol Chem. 1997 May 2;272(18):12189–12194. doi: 10.1074/jbc.272.18.12189. [DOI] [PubMed] [Google Scholar]
  17. Heppner K. J., Matrisian L. M., Jensen R. A., Rodgers W. H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol. 1996 Jul;149(1):273–282. [PMC free article] [PubMed] [Google Scholar]
  18. Jahkola T., Toivonen T., von Smitten K., Blomqvist C., Virtanen I. Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis. Int J Cancer. 1996 Dec 20;69(6):445–447. doi: 10.1002/(SICI)1097-0215(19961220)69:6<445::AID-IJC4>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  19. Jankowski J. A., Wright N. A., Meltzer S. J., Triadafilopoulos G., Geboes K., Casson A. G., Kerr D., Young L. S. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol. 1999 Apr;154(4):965–973. doi: 10.1016/S0002-9440(10)65346-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Johansson N., Airola K., Grénman R., Kariniemi A. L., Saarialho-Kere U., Kähäri V. M. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol. 1997 Aug;151(2):499–508. [PMC free article] [PubMed] [Google Scholar]
  21. Johansson N., Vaalamo M., Grénman S., Hietanen S., Klemi P., Saarialho-Kere U., Kähäri V. M. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol. 1999 Feb;154(2):469–480. doi: 10.1016/S0002-9440(10)65293-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kerkelä E., Ala-aho R., Lohi J., Grénman R., M-Kähäri V., Saarialho-Kere U. Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers. Br J Cancer. 2001 Mar 2;84(5):659–669. doi: 10.1054/bjoc.2000.1634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Koshikawa N., Giannelli G., Cirulli V., Miyazaki K., Quaranta V. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol. 2000 Feb 7;148(3):615–624. doi: 10.1083/jcb.148.3.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kusukawa J., Harada H., Shima I., Sasaguri Y., Kameyama T., Morimatsu M. The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity. Eur J Cancer B Oral Oncol. 1996 Jul;32B(4):217–221. doi: 10.1016/0964-1955(96)00016-4. [DOI] [PubMed] [Google Scholar]
  25. Kähäri V. M., Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med. 1999 Feb;31(1):34–45. doi: 10.3109/07853899909019260. [DOI] [PubMed] [Google Scholar]
  26. Lucas R., Holmgren L., Garcia I., Jimenez B., Mandriota S. J., Borlat F., Sim B. K., Wu Z., Grau G. E., Shing Y. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood. 1998 Dec 15;92(12):4730–4741. [PubMed] [Google Scholar]
  27. Martin D. C., Rüther U., Sanchez-Sweatman O. H., Orr F. W., Khokha R. Inhibition of SV40 T antigen-induced hepatocellular carcinoma in TIMP-1 transgenic mice. Oncogene. 1996 Aug 1;13(3):569–576. [PubMed] [Google Scholar]
  28. McDonnell S., Navre M., Coffey R. J., Jr, Matrisian L. M. Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinog. 1991;4(6):527–533. doi: 10.1002/mc.2940040617. [DOI] [PubMed] [Google Scholar]
  29. Mueller J., Werner M., Siewert J. R. Malignant progression in Barrett's esophagus: pathology and molecular biology. Recent Results Cancer Res. 2000;155:29–41. doi: 10.1007/978-3-642-59600-1_3. [DOI] [PubMed] [Google Scholar]
  30. Murphy G., Cockett M. I., Ward R. V., Docherty A. J. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J. 1991 Jul 1;277(Pt 1):277–279. doi: 10.1042/bj2770277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Murray G. I., Duncan M. E., O'Neil P., McKay J. A., Melvin W. T., Fothergill J. E. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol. 1998 Jul;185(3):256–261. doi: 10.1002/(SICI)1096-9896(199807)185:3<256::AID-PATH115>3.0.CO;2-A. [DOI] [PubMed] [Google Scholar]
  32. Nagase H., Woessner J. F., Jr Matrix metalloproteinases. J Biol Chem. 1999 Jul 30;274(31):21491–21494. doi: 10.1074/jbc.274.31.21491. [DOI] [PubMed] [Google Scholar]
  33. Ohashi K., Nemoto T., Nakamura K., Nemori R. Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer. 2000 May 15;88(10):2201–2209. [PubMed] [Google Scholar]
  34. Park H. I., Ni J., Gerkema F. E., Liu D., Belozerov V. E., Sang Q. X. Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor. J Biol Chem. 2000 Jul 7;275(27):20540–20544. doi: 10.1074/jbc.M002349200. [DOI] [PubMed] [Google Scholar]
  35. Peters J. H., Clark G. W., Ireland A. P., Chandrasoma P., Smyrk T. C., DeMeester T. R. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg. 1994 Nov;108(5):813–822. [PubMed] [Google Scholar]
  36. Pyke C., Rømer J., Kallunki P., Lund L. R., Ralfkiaer E., Danø K., Tryggvason K. The gamma 2 chain of kalinin/laminin 5 is preferentially expressed in invading malignant cells in human cancers. Am J Pathol. 1994 Oct;145(4):782–791. [PMC free article] [PubMed] [Google Scholar]
  37. Pyke C., Salo S., Ralfkiaer E., Rømer J., Danø K., Tryggvason K. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Cancer Res. 1995 Sep 15;55(18):4132–4139. [PubMed] [Google Scholar]
  38. Saarialho-Kere U. K., Chang E. S., Welgus H. G., Parks W. C. Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest. 1992 Nov;90(5):1952–1957. doi: 10.1172/JCI116073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Saarialho-Kere U. K., Pentland A. P., Birkedal-Hansen H., Parks W. C., Welgus H. G. Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest. 1994 Jul;94(1):79–88. doi: 10.1172/JCI117351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Saarialho-Kere U. K., Vaalamo M., Puolakkainen P., Airola K., Parks W. C., Karjalainen-Lindsberg M. L. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am J Pathol. 1996 Feb;148(2):519–526. [PMC free article] [PubMed] [Google Scholar]
  41. Shima I., Sasaguri Y., Kusukawa J., Yamana H., Fujita H., Kakegawa T., Morimatsu M. Production of matrix metalloproteinase-2 and metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer. 1992 Dec 15;70(12):2747–2753. doi: 10.1002/1097-0142(19921215)70:12<2747::aid-cncr2820701204>3.0.co;2-5. [DOI] [PubMed] [Google Scholar]
  42. Siri A., Knäuper V., Veirana N., Caocci F., Murphy G., Zardi L. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J Biol Chem. 1995 Apr 14;270(15):8650–8654. doi: 10.1074/jbc.270.15.8650. [DOI] [PubMed] [Google Scholar]
  43. Skyldberg B., Salo S., Eriksson E., Aspenblad U., Moberger B., Tryggvason K., Auer G. Laminin-5 as a marker of invasiveness in cervical lesions. J Natl Cancer Inst. 1999 Nov 3;91(21):1882–1887. doi: 10.1093/jnci/91.21.1882. [DOI] [PubMed] [Google Scholar]
  44. Sutinen M., Kainulainen T., Hurskainen T., Vesterlund E., Alexander J. P., Overall C. M., Sorsa T., Salo T. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer. 1998 Jun;77(12):2239–2245. doi: 10.1038/bjc.1998.372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Tanaka M., Itai T., Adachi M., Nagata S. Downregulation of Fas ligand by shedding. Nat Med. 1998 Jan;4(1):31–36. doi: 10.1038/nm0198-031. [DOI] [PubMed] [Google Scholar]
  46. Tani T., Lumme A., Linnala A., Kivilaakso E., Kiviluoto T., Burgeson R. E., Kangas L., Leivo I., Virtanen I. Pancreatic carcinomas deposit laminin-5, preferably adhere to laminin-5, and migrate on the newly deposited basement membrane. Am J Pathol. 1997 Nov;151(5):1289–1302. [PMC free article] [PubMed] [Google Scholar]
  47. Vaalamo M., Karjalainen-Lindsberg M. L., Puolakkainen P., Kere J., Saarialho-Kere U. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol. 1998 Apr;152(4):1005–1014. [PMC free article] [PubMed] [Google Scholar]
  48. Vaalamo M., Mattila L., Johansson N., Kariniemi A. L., Karjalainen-Lindsberg M. L., Kähäri V. M., Saarialho-Kere U. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol. 1997 Jul;109(1):96–101. doi: 10.1111/1523-1747.ep12276722. [DOI] [PubMed] [Google Scholar]
  49. Vaalamo M., Weckroth M., Puolakkainen P., Kere J., Saarinen P., Lauharanta J., Saarialho-Kere U. K. Patterns of matrix metalloproteinase and TIMP-1 expression in chronic and normally healing human cutaneous wounds. Br J Dermatol. 1996 Jul;135(1):52–59. [PubMed] [Google Scholar]
  50. Velasco G., Pendás A. M., Fueyo A., Knäuper V., Murphy G., López-Otín C. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem. 1999 Feb 19;274(8):4570–4576. doi: 10.1074/jbc.274.8.4570. [DOI] [PubMed] [Google Scholar]
  51. Westermarck J., Kähäri V. M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 1999 May;13(8):781–792. [PubMed] [Google Scholar]
  52. Yamamoto H., Adachi Y., Itoh F., Iku S., Matsuno K., Kusano M., Arimura Y., Endo T., Hinoda Y., Hosokawa M. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res. 1999 Jul 15;59(14):3313–3316. [PubMed] [Google Scholar]
  53. Yamashita K., Mori M., Shiraishi T., Shibuta K., Sugimachi K. Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma. Clin Cancer Res. 2000 Mar;6(3):1169–1174. [PubMed] [Google Scholar]
  54. van Sandick J. W., van Lanschot J. J., Kuiken B. W., Tytgat G. N., Offerhaus G. J., Obertop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut. 1998 Aug;43(2):216–222. doi: 10.1136/gut.43.2.216. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES